VIRTUALMAN

Essential solution

In the pharmaceutical industry, the risk compound chosen to develop may cost 2 years and 5 million dollars. VIRTUALMAN helps pharmaceuticals save time and money by decreasing their drug failures and offers optimization suggestions with explainable AI models.

Date of establishment:2019/9/23

Capital amount:$30,000,000

Fundraising round:A round

Website address

Company introduction

VIRTUALMAN predicts experimental results with clear optimization guidelines in the pre-clinical drug…

more...

Detailed solution introduction

VIRTUALMAN predicts experimental results with clear optimization guidelines in the pre-clinical drug…

more...

Contact information

Contact person:William Tien

Contact phone:(886)227090513

Mobile:

Email:contact@virtualman.ai

Startup teams

aetherAI, CO., LTD

Digital Pathology Workflow System and AI-Powered Diagnostic Support

Quantmetry

AI project developments and implementations

Instant NanoBiosensors Co., Ltd

Light-Sensing Biomarker Analyzer, a solution for diagnosing and monitoring patients after drug treat